UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 24 von 24

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain

Frontiers in immunology, 2023-10, Vol.14, p.1283251-1283251

2023

Volltextzugriff (PDF)

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning

Journal of clinical medicine, 2023-01, Vol.12 (3), p.931

2023

Volltextzugriff (PDF)

Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study

Annals of the rheumatic diseases, 2023-04, Vol.82 (4), p.496-506

2023

Volltextzugriff (PDF)

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.1419-1428

2021

Volltextzugriff (PDF)

No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2), p.e001345

2020

Volltextzugriff (PDF)

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

Rheumatology, 2023-10, Vol.62 (10), p.3382-3390

2023

Volltextzugriff (PDF)

Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.137

2023

Volltextzugriff (PDF)

Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model

Seminars in arthritis and rheumatism, 2022-12, Vol.57, p.152097-152097, Article 152097

2022

Volltextzugriff (PDF)

Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning

Frontiers in medicine, 2022-04, Vol.9, p.891863-891863

2022

Volltextzugriff (PDF)

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

Arthritis research & therapy, 2023-06, Vol.25 (1), p.109-109, Article 109

2023

Volltextzugriff (PDF)

Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.823-830

2022

Volltextzugriff (PDF)

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning

Arthritis research & therapy, 2022-06, Vol.24 (1), p.1-153, Article 153

2022

Volltextzugriff (PDF)

O24 Concomitant treatment with MTX does not increase the efficacy of ustekinumab or TFNi in PsA: results from the PsABio study

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

Síndrome de Cogan: descripción de un caso con respuesta parcial a tocilizumab y revisión de la literatura

Revista Colombiana de Reumatología, 2018-12, Vol.25 (4), p.298-300

2018

Volltextzugriff (PDF)

Síndrome de Cogan: descripción de un caso con respuesta parcial a tocilizumab y revisión de la literatura

Revista Colombiana de Reumatologia, 2018-10, Vol.25 (4), p.298-300

2018

Volltextzugriff (PDF)

Cogan's syndrome: A case report with partial response to tocilizumab and a literature review

Revista Colombiana de Reumatología (English Edition), 2018-10, Vol.25 (4), p.298-300

2018

Volltextzugriff (PDF)

Registro Español de Artritis Psoriásica de Reciente Comienzo (estudio REAPSER). Objetivos y metodología

Reumatología clinica, 2019-09, Vol.15 (5), p.252-257

2019

Volltextzugriff (PDF)

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

Reumatología clinica (Barcelona), 2019-09, Vol.15 (5), p.252-257

2019

Volltextzugriff (PDF)

P184 A 24-month prospective psoriatic arthritis observational study of persistence of treatment - interim analysis of baseline characteristics

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Volltextzugriff (PDF)

P182 Real-world persistence and treatment patterns in psoriatic arthritis patients treated with anti-IL17 therapy: the PERFIL-17 study

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Volltextzugriff (PDF)

Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy

Clinical and experimental rheumatology, 2009-11, Vol.27 (6), p.920

2009

Volltextzugriff (PDF)

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Arthritis research & therapy, 2006-01, Vol.8 (1), p.R29-R29, Article R29

2006

Volltextzugriff (PDF)

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

Reumatologia clinica, 2019-09, Vol.15 (5), p.252-257

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning

Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results

No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis

Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model

Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning

O24 Concomitant treatment with MTX does not increase the efficacy of ustekinumab or TFNi in PsA: results from the PsABio study

P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study

Síndrome de Cogan: descripción de un caso con respuesta parcial a tocilizumab y revisión de la literatura

Síndrome de Cogan: descripción de un caso con respuesta parcial a tocilizumab y revisión de la literatura

Cogan's syndrome: A case report with partial response to tocilizumab and a literature review

Registro Español de Artritis Psoriásica de Reciente Comienzo (estudio REAPSER). Objetivos y metodología

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

P184 A 24-month prospective psoriatic arthritis observational study of persistence of treatment - interim analysis of baseline characteristics

P182 Real-world persistence and treatment patterns in psoriatic arthritis patients treated with anti-IL17 therapy: the PERFIL-17 study

Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

Suchergebnisse filtern